3rd Edition of International Heart Congress
June 05-07,2025 | Hybrid Event
Cardiac Ablation
Cardiac ablation is a medical procedure designed to treat certain heart conditions, particularly those related to irregular heart rhythms or arrhythmias. During the procedure, a catheter is threaded through blood vessels to the heart, where it delivers energy in the form of heat or cold to the targeted areas responsible for the abnormal heart rhythms. This energy creates tiny scars, interrupting the abnormal electrical signals causing the arrhythmia. Cardiac ablation is often recommended when medications prove ineffective in managing irregular heartbeats. This minimally invasive procedure has proven to be a valuable intervention, providing relief for individuals with conditions such as atrial fibrillation. As technology advances, cardiac ablation continues to evolve, offering patients a promising option for restoring normal heart rhythm and improving overall cardiac health.
Shuping Zhong
University of Southern California, United States
Yong Xiao Wang
Albany Medical Center, United States
Yochai Birnbaum
Baylor College of Medicine, United States
Federico Benetti
Benetti Foundation, Argentina
Thomas Bernd Dschietzig
Relaxera GmbH & Co. KG, Germany
Mekhman N Mamedov
National Research Center for Preventive Medicine, Russian Federation
Narendra Kumar
HeartbeatsZ Academy, United KingdomSubmit your abstract Today
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain